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ABSTRACT
We have recently reported that a novel MBD2
interactor (MBDin) has the capacity to reactivate
transcription from MBD2-repressed methylated pro-
moters even in the absence of demethylation events.
Here we show that another unrelated protein, TACC3,
displays a similar activity on methylated genes.
In addition the data reported here provide possible
molecular mechanisms for the observed phenom-
enon. Immunoprecipitation experiments showed
that MBD2/TACC3 form a complex in vivo with the
histone acetyltransferase pCAF. MBD2 could also
associate with HDAC2, a component of MeCP1 rep-
ression complex. However, we found that the
complexes formed by MBD2 with TACC3/pCAF and
with HDAC2 were mutually exclusive. Moreover,
HAT enzymatic assays demonstrated that HAT
activity associates with MBD2 in vivo and that such
association significantly increased when TACC3
was over-expressed. Overall our findings suggest
that TACC3 can be recruited by MBD2 on methylated
promoters and is able to reactivate transcription
possibly by favoring the formation of an HAT-
containing MBD2 complex and, thus, switching the
repression potential of MBD2 in activation even
prior to eventual demethylation.
INTRODUCTION
Methylated DNA is generally associated with transcript-
ional silencing. Several recent studies have addressed the
mechanisms by which methyl-CpG signal is targeted, read
and maintained by the different components of the DNA
methylation system. A family of mammalian methyl-CpG-
binding proteins, including MeCP2, MBD1, MBD2, MBD3,
Kaiso and MBD4, has been found to be essential to interpret
the methylation patterns and to mediate the biological con-
sequences of DNA methylation (1–4). All methyl-binding
proteins share a common structural stretch of 60–80 amino
acids called mCpG-binding domain (MBD) and, with the
exception of MBD4 (5), may mediate transcriptional repres-
sion by changing the local chromatin structure mainly through
recruitment of histone deacetylases (HDACs) (1–3,6,7).
However, it seems likely that the activity of methyl-binding
proteins depends on their association with different molecular
partners. The best example of a multiple functions methyl-
binding protein is MBD2. MBD2 exerts different activities
depending on its association with different partners. MBD2
can be a component of a large proteincomplex, MeCP1, which
represses transcription from densely methylated genes.
MeCP1 includes HDAC1, HDAC2 and RbAp46/48 proteins
(6,7). This way, MBD2 targets deacetylase activity at methyl-
ated sites. MBD2 can also recruit on methylated DNA a dif-
ferent corepressor complex, Mi-2/NuRD, through its
heterodimerization withMBD3 (8,9). Otherauthorshave iden-
tiﬁed a protein, MIZF, that associates with MBD2 and signi-
ﬁcantly enhances HDAC proteins recruitment and activity
(10). In addition, MBD2 forms a complex with DNA methyl-
transferase 1 (DNMT1) on hemimethylated DNA at replica-
tion foci and may help to establish or maintain the repressed
state of chromatin (11). While the above described functions
result in transcriptional repression, recently it is emerging that
when MBD2 associates with other partners, it may have
opposite effects resulting in transcriptional activation of
methylated genes. In a recent study, it was shown that the
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doi:10.1093/nar/gkj400viral protein Tax can activate transcription from the methyl-
ated HTLV-1 long terminal repeat through the interaction with
MBD2 (12). The transcription factor GATA-3 can displace
MBD2 from a methylated promoter causing the transcriptional
reactivation of GATA-3 responsive genes (13). We have
recently described a novel MBD2 associating protein,
MBDin, which shows the unique ability to reactivate
MBD2-repressed genes still in methylated status (14). In
the case of MBDin-mediated reactivation, as well as for
GATA-3, transcriptional reactivation occurs prior to
demethylation. However, MBDin is recruited by MBD2 on
methylated DNA and acts by interfering with the ability of
MBD2 to associate with the repressor complex rather than
through displacement of MBD2 from methyl-CpG sites
(14). Recently it has been shown that MBD2 interacts with
RNA helicase A, a component of CREB transcriptional co-
activator complex (15). All these mechanisms lead to activa-
tion of methylated genes not through a possible active
demethylase function of MBD2, but, rather, through the asso-
ciation of MBD2 with a variety of factors that can be recruited
on methylated DNA and determine different interpretations of
DNA methylation signals.
In the present work we have identiﬁed TACC3
(transforming-acid-coiled–coil), as a novel MBD2 associating
protein. We demonstrate that MBD2 and TACC3 may interact
both at centrosomes in mitosis and in the interphase nucleus.
We show that TACC3/MBD2 may form a complex with
histone acetyltransferases and reactivate transcription from
methylated genes. Our ﬁndings provide a possible general
mechanism by which methylated genes can be reactivated
through a switch from a closed to an open chromatin
conﬁguration.
MATERIALS AND METHODS
Construction of fusion genes and expression plasmids
Plasmids pBridge-MBD2, pGal4-MBD2, pBridge DMBD2,
pBridge-MUT1, pBridge-MUT3 and pBridge-MUT4, used for
two-hybrid screening and speciﬁcity tests, and pMyc-MBD2
for immunoprecipitation experiments, have been described
previously (14). The plasmid hTACC3 pCR2 Topo cloning
(kindly provided by T. R. J. Lappin) containing the full length
TACC3 coding sequence (16) was partially digested with
EcoRI and the entire TACC3 cDNA was subcloned into the
EcoRI sites of pCEFL-HA expression vector (17) to generate
pHA-TACC3. pHA-DTACC3 expression vector was gener-
ated by cloning a 1290 bp TACC3 fragment (amino acids
409–837) into pCEFL-HA (EcoRI and XbaI sites). Primers
used for ampliﬁcation, containing restriction sites (under-
lined), were: TACC3D-EcoRI/F (50-AGTC GAA TTC ATG
GAT GAC CCA AAC TTC ATC-30) and TACC3-XbaI/R
(50-AGTC TCT AGA AGG TCA GAT CTT CTC CAT
CTT G-30).
Yeast two-hybrid assay
We performed yeast two-hybrid screens by yeast mating
according to the manufacturer’s instructions (Clontech).
We used a human bone marrow and a brain cDNA libraries
pretransformed in the Y187 Saccharomyces cerevisiae strain
cloned downstream of the Gal4AD in the pGADGH plasmid
(Clontech). pBridge-MBD2 (14) was used as a bait and trans-
formed in the PJ692A S.cerevisiae strain using the lithium
acetate method and then treated according to the manu-
facturer’s instructions. The diploid strains were cultured on
high stringency plates lacking histidine, adenine, tryptophan
and leucine. The resultant clones were tested for b galactosi-
dase activity using a colony-lift ﬁlter assay (18). Puriﬁcation
and sequencing of positive clones, tests for interaction speci-
ﬁcity and measurement of protein interaction were performed
as described (14).
Cell culture, transient transfections and CAT assays
293T, MCF7 and Cos-7 cells were cultured in DMEM sup-
plemented with 10% fetal calf serum (Life Technologies).
Cells were plated at a density of  5 · 10
5 per 100 mm
Petri dish 24 h before transfections. DNA transfections
were carried out by calcium phosphate precipitation using
Calphos (Clontech) or lipofectAMINE  plus reagents (Invit-
rogen) according to the manufacturer’s instructions. For
transcription assays, cultures were cotransfected with testplas-
mids (5 mg) and different amounts of effector plasmids as
indicated in the text. The b-galactosidase expression plasmid,
pSVb gal (Promega) (2 mg), was used as an internal control
for transfection efﬁciency. Chloramphenicol acetyltransferase
(CAT) assays were performed with different amounts of
extracts to ensure linear conversion of the chloramphenicol
with each extract and the results are presented as the means
of at least three independent transfection experiments. The
CAT activity was quantiﬁed using the Molecular Dynamics
PhosphorImager System TM. Total protein extracts (5 mg)
were assayed for b galactosidase activity as previously
described (19).
Rat thyroid PC Cl3 cell lines were maintained in
Coon’s modiﬁed F12 medium (EuroClone, Milano, Italy) sup-
plemented with 5% newborn calf serum (HyClone, Logan,
UT) and six growth factors (6H), including TSH (1 mU/ml),
and insulin (10 mg/ml) as previously described (20).
DNA transfections were carried out by lipofectAMINE 
plus reagents (Invitrogen) according to the manufacturer’s
instructions.
Drug treatments and quantitative RT–PCR analysis
PC Cl3 cells were treated with different amounts of trichos-
tatin A (TSA, Invitrogen) or of 5-aza-20-deoxycytidine (ICN
Biomedical Inc.) for 36 h. Total RNA was isolated with
TRIzol Reagent (Invitrogen).QantiTectReverseTranscription
kit (QUIAGEN) was used to generate cDNA. The following
galectin-1-speciﬁc primers were used: Gal-1/Fw (50-CTCG-
GGTGGAGTCTTCTGAC-30) and Gal-1/Rv (50-TCCCCAG-
GTTTGAGATTCAG-30). Ampliﬁcation of rat G6PD cDNA
was used as the endogenous control using the following
primers: G6/fw (50-TCCTCTATGTGGAGAATGAACG-30)
and G6/rev (50-TCATTCAGAGCTTTGCCACA-3). Quantit-
ative PCR ampliﬁcations were then performed using sybr
green (Applied Biosystems) in a Chromo4 Real Time thermo-
cycler (BIORAD). Calculations of relative expression levels
were performed using the 2
 DDCt method (21).
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293T and MCF7 cell extracts were prepared in Nonidet
P-40 lysis buffer (1% NP-40, 50 mM Tris–HCl pH 8.0,
150 mM NaCl) with proteinase inhibitors (Roche Molecular
Biochemicals). Immunoprecipitations were performed as
described previously (17). The samples were immunoprecipi-
tated with mouse monoclonal anti-HA (Roche Molecular
Biochemicals), mouse anti-myc, rabbit anti-HDAC2 and
mouse anti-pCAF antibodies (Santa Cruz), and resolved on
12 and 10% SDS–PAGE. Immunoprecipitated (IP) proteins
were analysed by immunoblotting performed by using goat
polyclonal anti-HA, mouse anti-myc, goat anti-TACC3, rabbit
anti-HDAC2, mouse anti-pCAF (Santa Cruz) and rabbit anti-
MBD2a (Abcam) antibodies. Immunoblots were stained with
correspondent secondary antibodies (Amersham Biosciences)
and revealed with the enhanced chemiluminescence detection
system (Amersham Biosciences).
In vitro DNA methylation
pGAT1700 plasmid (50 mg) (22) were treated with 50 U of
SssI methylase (New England Biolabs) at 37 C in the presence
of 5 mM adenosylmethionine for 8 h. Complete methyla-
tion of treated plasmids was conﬁrmed by HpaII restriction
enzyme digestion (data not shown). After transfections,
cells were harvested and used for transcription assays.
Methylation status of pGAT1700 plasmid was determined
by bisulﬁte analysis at different times after transfections, as
previously described (14).
Immunocytofluorescence
Cos-7 and NIH3T3 cells were incubated in 8% BSA in
phosphate-buffered saline (PBS) for 1 h at room temperature
(RT). Cells were then incubated with primary antibodies:
goat polyclonal anti-MBD2 antibodies (1:200), mouse mono-
clonal anti-g-tubulin (Sigma) (1:2000), rabbit polyclonal
anti-MBD2a (Abcam) antibodies and goat polyclonal anti-
TACC3 and were diluted in 2% BSA–PBS incubated 2 h at
RT. For double immunoﬂuorescent staining, the primary anti-
bodies were incubated in unison. After extensive washing with
PBS, these antibodies were detected by appropriate secondary
antibodies as follows: Alexa Fluor 488-conjugated goat anti-
mouse Ig antibodies (Molecular probes), Alexa Fluor 568-
conjugated rabbit anti-goat Ig antibodies (Molecular probes),
Alexa Fluor 568-conjugated goat anti-rabbit Ig antibodies and
Alexa (Molecular probes) and Fluor 488-conjugated rabbit
anti-goat Ig antibodies (Molecular probes). Secondary anti-
bodies were diluted 1:100 in 2% BSA–PBS and incubated
for 45 min at RT. Cells were then incubated in PBS containing
5 mg/ml of 40,6-diamidino-2-phenylindole (DAPI) for 10 min
at RT. After incubation, the cells were washed in PBS and
coverslips were mounted with 4.8% Mowiol in 50 mM Tris
pH 8.5. Images were obtained using a Zeiss Axioskop MC 100
ﬁtted with a camera and all the images were acquired with a
60· Plan-Neoﬂuar objective. Images were subjected to scale
adjustment using image software (Photoshop, Adobe Systems,
Inc., San Diego, CA).
Non-radioactive Histone Acetyltransferase
Activity Assay
293T cells were transfected and nuclear extracts immuno-
precipitated with mouse monoclonal anti-Myc, and subjected
to the assay. Nuclear proteins were differentially extracted by
lysing cells in ice-cold hypotonic buffer (0.2% NP-40, 10 mM
HEPES, pH 7.9, 1 mM EDTA, 60 mM KCl). Nuclei were
separated through a 60% sucrose cushion and lysed in HB
buffer (250 mM Tris–HCl, pH 7.8, 60 mM KCl) by freeze-
and-thaw treatment. Non-radioactive HAT assay was done
using a HAT assay kit (Upstate Biotechnology, Inc.), accord-
ing to the manufacturer’s protocol. Brieﬂy, each immuno-
precipitated fraction of nuclear extract, mixed with 100 mM
acetyl-CoA and 1·HAT assay buffer, was incubated on an
enzyme-linked immunosorbent assay plate precoated with his-
tones H3 and H4 for 5 or 10 min. After several washes with
Tris-buffered saline, acetylated histones were detected using
an anti-acetyl-lysine rabbit polyclonal antibodies followed by
the horseradishperoxidase-basedcolorimetric assay.Arecom-
binant pCAF (25 ng) (Upstate Biotechnology, Inc.) was used
as a positive control. Data were expressed as optical density
(OD) at 450 nm.
RESULTS
Interaction screening
To identify news partners of the MBD2 protein, we performed
interaction screening using the two-hybrid system in yeast
(Clontech). We have simultaneously analysed a bone marrow
and a brain cDNA libraries. A total of  3 · 10
6 clones were
tested for each library using the short form of MBD2 cDNA,
MBD2b, as bait (14). After the speciﬁcity of interaction was
assessed (see Materials and Methods), we have identiﬁed a
total of 92 positive clones (41 and 51 from bone marrow and
brain, respectively). These clones contained cDNA inserts
between 512 and 2779 bp, and, after sequencing, we could
dividethemin11differentgroupseach containing3–12clones
with different insert length but containing the same cDNAs.
Most groups contained clones derived from the same library,
possibly reﬂecting the tissue-speciﬁc nature of the cDNAs,
while some others contained identical cDNAs derived from
both libraries. Interestingly, most groups contained cDNAs
encoding for transcriptional repressors or activators. We
chose to analyse in detail Group F, which included eight
clones, all derived from bone marrow library and each con-
taining part of the coding sequence of transforming acid
coiled–coil protein 3, TACC3 (DDBJ/EMBL/GenBank acces-
sion number AJ243997). TACC3 was a very interesting can-
didate MBD2 interactor because of its capacity to associate
with chromatin remodeling factors (23). TACC3 is a 100 kDa
protein belonging to the family of transforming-acidic coiled–
coil containing (TACC) proteins including three human mem-
bers (24–26). TACC3 contains three domains (Figure 1A): a
conserved N-terminal region of 108 amino acids, encoded by
exons 2 and 3 in each vertebrate TACC3 gene, an highly
variable central region and the conserved TACC domain
(C-terminal region from amino acids 636 to 837) that share
 60% identity with the C-terminal region of TACC1 and
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tained the entire TACC domain. The shortest one (pGAD-F3)
contained TACC3 sequences encoding a 267 amino acids
polypeptide (from amino acids 571 to 837) indicating that
this region of TACC3 is sufﬁcient for the interaction with
MBD2 (Figure 1A).
Interaction of MBD2 deletion mutants
with TACC3 in yeast
To narrow the regions of MBD2 able to interact with TACC3,
deletion experiments were performed in yeast. As shown in
Figure 1B, deletion of MBD2 N-terminal 103 amino acids
(pBridge-DMBD2) did not affect the ability of MBD2 to asso-
ciate with TACC3, demonstrating that the methyl-binding
domain (MBD) is dispensable for the interaction. The further
removal of 100 amino acids at the C-terminus (pBridge-
MUT1) abolished the capacity of MBD2 to bind TACC3
showing that the C-terminal region is necessary for the inter-
action. The analysis of pBridge-MUT3 and pBridge-MUT4
demonstrated that the MBD2 region from amino acids 156 to
216 is sufﬁcient for the interaction with TACC3, while the
extreme C-terminus (amino acids 216–262) is dispensable.
Immunoprecipitation experiments
Coimmunoprecipitation experiments were performed to
investigate whether MBD2 and TACC3 form a complex in
mammalian cells (Figure 2). 293T cells were transfected with
expression vectors containing the myc-tagged full length
MBD2 cDNA (pMyc-MBD2), together with HA-tagged full
length TACC3 cDNA (pHA-TACC3) or a TACC3 mutant
form containing the C-terminal 429 amino acids (pHA-
DTACC3). Subsequently, cell lysates were immunoprecipit-
ated with anti-HA antibodies. The immunoprecipitated
fractions and whole cell extracts were then immunoblotted
and hybridized with anti-myc or anti-HA antibodies. As
shown in Figure 2, both TACC3 and DTACC3 coimmuno-
precipitated with MBD2 (Figure 2A and B, respectively).
Empty vectors were also cotransfected as negative controls.
These results conﬁrm that in mammalian cells MBD2 and
TACC3 form a complex and that the TACC3 C-terminal
region (amino acids 409–837), containing the TACC domain,
is sufﬁcient for the interaction.
TACC3 affects the activity of methylated promoters
To explore whether TACC3 could affect the transcriptional
repression potential of MBD2, we performed transient trans-
fection assays into human 293T cells using a methylated
promoter. To this aim we have used a CAT reporter
plasmid (pGAT1700) (22) containing 1700 bp of the mouse
galectin-1 promoter that can be repressed by in vitro DNA
methylation (27) and, when methylated, is bound by MBD2
(14). Transcription assays were performed after transfection of
MBD2 and TACC3 expression vectors, along with either
unmethylated or in vitro methylated pGAT1700 construct
in 293T cells. The results (Figure 3A) clearly showed that
TACC3 was able to reactivate, in a dose dependent manner,
Figure 1. Definition of MBD2 and TACC3 binding region in yeast. (A) Schematic representation of structural and functional domains of MBD2 and TACC3
proteins. For MBD2, the methyl-binding-domain (MBD) is indicated as a black box; the putative coiled–coil domain is indicated as a gray box. For TACC3, the
stripedboxcontainsaconservedN-terminalregionandtheTACCdomainisindicatedasagraybox.TACC3-mir(minimalinteractingregion)representstheminimal
TACC3 region interacting with MBD2 in yeast. (B) Mapping of the TACC3-binding region of MBD2 by yeast two-hybrid experiments. Full length and deletion
mutants of MBD2 were fused to GAL4 DNA binding domain (bait) and the TACC3-mir (amino acids from 571 to 837) was fused to the GAL4 activation
domain (pGAD-F3 plasmid clone). The interaction between the bait proteins and prey was tested on the basis of the His and Ade reporter gene activation and by
quantitative liquid b-galactosidase assay.
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ivation was much stronger in the presence of over-expressed
MBD2, indicating that MBD2 is essential for the recruitment
ofTACC3onthemethylatedpromoter.Incontrast,theactivity
of unmethylated pGAT1700 was not signiﬁcantly affected
by either TACC3 or MBD2 exogenous expression (data not
shown). To exclude that reactivation of the methylated pro-
moter was a consequence of a demethylation event, we per-
formed, in parallel with transcriptional assays, a sodium
bisulﬁte methylation analysis. Seven CpG sites contained in
the  177/+11 region of the transfected mouse galectin-1 pro-
moter, whose methylation state is critical for transcriptional
activity (14,28,29), were analysed using mouse-speciﬁc bisul-
ﬁte-modiﬁed primers. No signiﬁcant change of methylation
pattern was observed up to 60 h after transfection of the
reporter gene alone or in combination with TACC3 and/or
MBD2 (data not shown) indicating that the reactivation
observed in the transcriptional assays occurred when the pro-
moter was still in a fully methylated status.
Finally, we investigated whether TACC3 was able to react-
ivate endogenous methylated genes. We used a rat thyroid cell
line, PC Cl3, in which galectin-1 endogenous gene is heavily
methylated and barely expressed (27). Our results showed
that exogenous expression of TACC3, as well as treatment
of cells with the deacethylase inhibitor TSA or the demethyl-
ating drug azacytidine, induced a signiﬁcant increase of
endogenous galectin-1 gene expression within 36 h in a dose
dependent manner (Figure 3B). Moreover our results showed
that TACC3 displays a synergistic effect with TSA treatment
(Figure 3B).
Figure 2. In vivo association of MBD2 with TACC3 and DTACC3. 293T cells
were transfected in the indicated combinations with the following expression
plasmids: (A) pHA-TACC3, pMyc-MBD2 and control empty vectors;
(B) pHA-DTACC3, pMyc-MBD2 and control empty vectors. The whole
cell extracts were prepared and subjected to immunoprecipitation with goat
polyclonal anti-HA antibodies. Immunoprecipitated (IP) proteins were ana-
lysed by immunoblotting with mouse monoclonal anti-Myc and anti-HA
antibodies.
Figure 3. Influence of MBD2 and TACC3 over-expression on activity
of methylated transfected or endogenous galectin-1 promoter activity.
(A) 293T cells were transfected with 3 mg of unmethylated (gray bar) or in
vitro methylated (black bars) pGAT1700 reporter plasmid. Cotransfected ex-
pressionplasmidswerepSVb(2mg)and,whereindicated,pMyc-MBD2(2mg)
and pHA-TACC3 at different amounts. The level of transcription is given as a
percentage of CAT activity seen in the presence of unmethylated pGAT1700
reporter plasmid alone (set as 100%). Percent relative activity of the promoters
is expressed as the ratio of CAT to b-galactosidase activity. The results are
presented as an average of multiple experiments +/  SD. Each histogram bar
representsthemeanofatleastfourindependenttransfections.(B).Quantitative
RT–PCR assays of endogenous galectin-1 mRNAs were performed on PC Cl3
cells untreated or treated with the indicated concentrations of 5-aza-20-
deoxycytidine (Aza) or Trycostatin A (TSA) for 36 h. Where indicated
(TACC3), cells were transfected with pHA-TACC3 expression vector. mRNA
expressionlevelsareshownasfold-inductioncomparedwiththePCCl3value,
arbitrarily set as 1. The results are presented as an average of at least three
independent experiments +/  SD.
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acetyltransferase (pCAF)
We next investigated potential mechanisms that could account
for the observed effects of MBD2/TACC3 complex on the
activity of methylated promoters. Because TACC3 was
recently found in a protein complex containing endogenous
histone acetyltransferases (23), we hypothesized that TACC3
might favor a switch to an open chromatin conﬁguration on
MBD2-bound promoters. We therefore investigated the pos-
sibility that MBD2, through the interaction with TACC3, may
recruit HATs on methylated promoter. To test this hypothesis,
we used a breast cancer cell line (MCF7) in which endogenous
TACC3 forms a complex with pCAF (23). In this cell line,
MBD2a and HDAC2 endogenous proteins were expressed
at detectable levels, as evidenced by western blot analysis
(Figure 4). Immunoprecipitation experiments were performed
using anti-Myc, anti-MBD2a, anti-pCAF and anti-HDAC2
antibodies, respectively, and western blots were performed
using the same antibodies and, in addition, the anti-TACC3
antibodies (Figure 4). Results showed that both exogenous
Myc-tagged MBD2b (Figure 4A) and endogenous MBD2a
(Figure 4B) proteins form a complex with pCAF and
TACC3. MBD2 couldalsobind HDAC2, as extensively repor-
ted (6,7). However, our experiments show that the complexes
formed with MBD2 by HDAC2 and by TACC3/pCAF were
mutually exclusive (Figure 4B).
In order to investigate whether the formation of MBD2/
TACC3/pCAF complex is cell cycle speciﬁc, similar immuno-
precipitation experiments were performed in synchronized
MCF7 cells. Cells were grown for 12 h in the presence of
0.5% serum. Immunoprecipitation experiments were per-
formed at time points 0, 1, 3, 6, 12, 18 and 24 h after 10%
serum was restored. Results show that the MBD2/TACC3/
pCAF complex was present at all time points (data not
shown) indicating that the formation of the complex is not
cell cycle speciﬁc.
HAT activity associates with MBD2
The above experiments indicate that MBD2 and the acetyl-
transferase pCAF may be part of a protein complex. Thus,
we next analysed whether HAT enzymatic activity could be
associated with MBD2 and whether TACC3 may favor such
association. For this purpose, 293T cells were transfected with
pMyc-MBD2 alone or in combination with pHA-TACC3
expression vector. Then, the HAT enzymatic activity,
coprecipitating with MBD2, was assayed. The assays were
performed both on histones H3 and H4. The results, presented
in Figure 5, show that HAT activity consistently associated
with MBD2 protein even in the absence of exogenous TACC3
Figure 4. In vivo interactions of MBD2, TACC3, pCAF and HDAC2. (A) Cell lysates from MCF7 untransfected cells (NT) or transfected with pMyc-MBD2
plasmid (T) were immunoprecipitated (IP) and immunoblotted with the indicated antibodies. Anti-myc antibodies were used to detect Myc-MBD2 fusion protein.
WCE: whole cell extract. (B) whole cell lysates from MCF7 cells were subjected to immunoprecipitation with anti-HDAC2 antibodies, as indicated. Western blots
were performed with the indicated antibodies. Anti-MBD2a antibodies were used to detect endogenous MBD2a protein.
Figure 5. Analysis of MBD2-associated acetyltransferase activity. 293T cells
weretransfectedwithpMyc-MBD2(4mg)(lane2)aloneorincombinationwith
pHA-TACC3 (2 mg) (lane 3). After 48 h transfection nuclear extracts were
immunoprecipitated with anti-Myc antibodies. Recombinant pCAF (25 ng)
(lane 1) and immunoprecipitated fractions from untransfected cells (lane 4)
were used as controls. The HAT activity of each immunoprecipitated fractions
was determined by in vitro colorimetric HAT assay. Incubation times of the
assayswere5min(graycolumns)and10min(blackcolumns).Theacetylation
status of histones H3 (top panel) and H4 (bottom panel) is represented as OD
values at 450 nm.
Nucleic Acids Research, 2006, Vol. 34, No. 1 369expression. However, TACC3 over-expression signiﬁcantly
enhanced the MBD2-associated HAT activity, in particular
when H4 was used as a substrate.
These data suggest that MBD2 associates with HATs in a
direct manner or, more likely, through different bridge pro-
teins and that TACC3 may actively contribute in providing the
MBD2 complex with HAT activity.
Centrosomal localization of MBD2
Finally, because TACC3 localizes at centrosomes in mitosis
(25),wetested thepossibilitythatMBD2 proteinisrecruited at
centrosomes as well. Asyncronous Cos-7 cells were subjected
to immunostaining study using goat anti-MBD2 antibodies
(red) and mouse anti-g-tubulin antibodies (green) as centro-
somes indicator. In interphase, MBD2 localizes in the nucleus
(Figure 6A, a), as extensively reported (1,13,14). In contrast,
during different phases of mitosis, MBD2 mainly localizes at
centrosomes (Figure 6A, b and c).
Inorder to establish whether MBD2 and TACC3co-localize
in interphase nuclei, we performed an immunoﬂuorescence
analysis in NIH3T3 mouse cells. Results showed that
TACC3 partially colocalizes with MBD2 at nucleus
(Figure 6B). However, localization of TACC3 was diffuse
and not limited to the spots of hypermethylated DNA
which was seen for MBD2 and in concordance with possible
multiple functions of TACC3 in interphase nuclei.
These observations indicate that TACC3 and MBD2 asso-
ciate both in interphase nucleus and at centrosomes during cell
division.
Interestingly, other components of the NuRD complex, such
as MBD3 and HDAC1, have been recently localized at mitotic
centrosomes (30). Our ﬁndings further support the hypotesis
that the NuRD complex play a yet uncharacterized, cell
cycle controlled, role at the centrosomes and suggest that
TACC proteins may be involved in this subcellular localiza-
tion during mitosis.
DISCUSSION
In the present work we show that TACC3 associates with
MBD2 and may form a complex with histone acetyltrans-
ferases switching the MBD2-mediated transcriptional repres-
sion to activation without involving promoter demethylation.
Searching for MBD2 partners, we have recently demon-
strated that MBDin, a novel GTPase protein, is able to asso-
ciate with MBD2 and to reactivate methylated genes without
altering the methylation pattern of the target genes (14). How-
ever, the mechanisms underlying this phenomenon remain
poorly understood. In the present study we have speciﬁcally
selected other MBD2 partners that might share with MBDin a
similar activity. Among several clones positive for MBD2
interaction in yeast, TACC3 was chosen because of its poten-
tial ability to associate with histone acetyltransferases, as
recently reported (23). Compatible with a physiological rel-
evance of their interaction, TACC3 and MBD2 are ubiquit-
ously expressed in mammalian tissues, even if the relative
proportion may vary among different tissues. (1,24).
TACC3 belongs to a recently identiﬁed and evolutionary
conserved protein family referred as TACC family (24,26).
Mammalian TACC genes encode highly acidic proteins char-
acterized by a conserved and unique 200 amino acids coiled–
coil domain termed the ‘TACC domain’, but lacking signiﬁc-
ant homology outside this domain. All the TACC proteins are
associated with the mitotic centrosome/spindle apparatus (25)
and localize in the nucleus during interphase. In particular, for
TACC3, the nucleus represents the major interphase subcel-
lular localization. Noticeably, as mentioned above, it has been
recently demonstrated that TACC2 and TACC3 proteins may
form a complex with different histone acetyltransferases,
including pCAF. Thus, it has been proposed that such a mech-
anism could account for the observed function of TACC3 as a
transcriptional co-activator of different nuclear factors
(23,31).
In the present paper we show that TACC3, as well as
MBDin, has the capacity to relieve the MBD2-mediated tran-
scriptional repression of methylated genes even in the absence
of demethylation events. The protein structure of TACC3 does
not display any evident feature in common with MBDin and
the interaction with MBD2 occurs through different regions of
this methyl-binding protein. While MBDin interacts with the
extreme C-terminal of MBD2 (amino acids 216–262) here we
found that the same region is not essential for the association
with TACC3 which, instead, occurs through a more proximal
portion of MBD2 (amino acids 156–216). This is compatible
with a simultaneous binding of the two partners to MBD2 and
with eventual synergistic activities. Moreover, we show that
Figure 6. (A) MBD2 localizes at centrosomes in M phase. Asyncronous
Cos-7 cells were subjected to immunofluorescence study using goat anti-
MBD2 antibodies (red) and mouse anti-g-tubulin antibodies (green). DNA
was stained with DAPI (blue). (a) interphase; (b) metaphase and (c) anaphase.
(B) MBD2/TACC3 colocalization in NIH3T3 cells in interphase nucleus.
370 Nucleic Acids Research, 2006, Vol. 34, No. 1the C-terminal region of TACC3 (amino acids 571–837) is
sufﬁcient for the interaction with MBD2 both in yeast and in
mammalian cells. This region include the TACC domain,
raising the possibility that other members of the TACC family
might associate with MBD2. Further investigation will be
necessary to verify the occurrence and the functional role
of such potential multiple interactions.
WhileitiswellknownthatMBD2isanessentialcomponent
of the chromatin repressor complex such as the MeCP1 com-
plex, which includes different histone deacetylases (HDAC1
and HDAC2), the possibility that MBD2 could form alternat-
ive complexes with HATs, natural antagonist of deacetylases,
has been to date poorly investigated. Because TACC3 asso-
ciates with the histone acetyltransferase pCAF (23), we have
addressed the intriguing possibility that MBD2, as a partner of
TACC3, could also be part of the same complex. Coimmuno-
precipitation experiments of both exogenous and endogenous
proteins showed that this was the case (Figures 2 and 4). It has
been reported that some transcription factors (YY1 and Sp1)
may interact with both HATs and HDACs, thereby acquiring
an activator or repressor function depending on the promoter
context or on the presence of other factors (32). Recently, it
has also been demonstrated that HAT and HDACs directly
interact and immunoprecipitate in the same fractions (33). Our
data indicate that, although both TACC3/pCAF and HDAC2
may associate with MBD2 in MCF7 cells, they are part of
distinct complexes (Figure 4). In any case our ﬁndings rein-
force the general concept that the actual activity of a promoter
depends on a dynamic equilibrium of HATs and HDACs
recruitment (33) and extend this view to the mechanisms regu-
lating the activity of methylated promoter. It is likely that
methyl-binding proteins play a central role in the establish-
ment of such equilibrium on methylated genes. In fact, our
data show that, in addition to HDAC, also HAT enzymatic
activity associates with MBD2 in vivo. Interestingly, we
observed that a large amount of HAT activity associates
with MBD2 even in the absence of TACC3 indicating that
TACC3 may favor such association but it is not essential.
Although our data show that the reactivation of methylated
galectin-1 gene occurs in a short time in the absence of
demethylation events, we cannot exclude the intriguing pos-
sibility that the acetylation might trigger promoter demethyla-
tion in a longer period. In conclusion, our data suggest that
MBD2 is not just a simple mediator of transcriptional repres-
sion functioning by recruitment of chromatin repressor com-
plexes on densely methylated promoters. We wish to propose
that methyl-binding proteins may mediate both transcriptional
repression and reactivation of methylated genes depending on
the dynamic equilibrium of enzymatic activities recruited on
methylated promoters. Different proteins, including TACC3,
might favor a prevailing recruitment of HAT activity, there-
fore leading to changes of chromatin conﬁguration sufﬁcient
to reactivate methylated genes even in the absence of
demethylation events.
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